Health & Medicine
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
Exploring how Kazia Therapeutics’ novel nuclear PD-L1 protein degrader, NDL2, works to overcome immunotherapy resistance in advanced solid tumors.
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
Discover the preliminary clinical evidence thresholds cell therapies must achieve to secure simultaneous FDA RMAT and Fast Track designations.
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
Following successful Phase 3 trial results, mRNA platforms are emerging as a versatile, rapid tool for training the immune system to target…
-
NHS rolls out first targeted anal cancer drug, extending survival to nearly three years
Retifanlimab plus chemotherapy adds 10 months of life for 250 patients annually in England, available immediately.
Personal Finance
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
Fidelity’s new retirement investing strategy impacts fees and access for average 401(k) savers, requiring careful review of statements.
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
Break down the concept of RMDs, their rules, current age thresholds, and practical tips like Roth conversions for managing tax implications.
-
How Retirement Savers Can Close the Gap Left by the Fading Three-Legged Stool
Discover actionable strategies to diversify income sources and boost personal savings rates as the traditional retirement model collapses.
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
The IRS raises the elective deferral limit by $1,000 and expands catch-up contributions for workers 50 and older, creating new tax-deferral opportunities.
Cancer News
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
Phase 1 data show 87% response and 18-month PFS; pivotal phase 2 met goals but BMS withheld numbers as phase 3 begins.
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
The FDA’s August 2026 approval of iberdomide introduces a new class of cancer drugs for patients with relapsed or refractory multiple myeloma.
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
A phase 1 trial of an engineered CD40 antibody published in Cancer Cell found tumor shrinkage in half of 12 patients, with…
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
WASHINGTON, July 7 — A 13-year gap between a mother’s breast cancer diagnosis and her daughter’s own diagnosis has laid bare persistent…
Health News
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
LONDON, July 15 — The shift is stark: a new study from the Indiana University School of Medicine suggests bowel cancer patients…
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
WASHINGTON — A new study suggests that drinking water with meals may trigger a psychological compensation mechanism, leading individuals to eat more.…
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
World News
-
The Black Sea Grain Initiative: A Deal That Collapsed in 2023
ISTANBUL, July 14 — The Black Sea Grain Initiative, a diplomatic arrangement that once allowed over 32 million metric tons of grain…
-
Kenyan families mark two years since 2024 protests with flowers, marches and calls for accountability
Nairobi, June 25 — As Kenya approaches the anniversary of the June 2024 protests, families of the victims are speaking out about…
-
Five Die After Car Hits Parked Truck on Hyderabad Outer Ring Road Near Adibatla
Pedda Amberpet Crash: Five Families Wait for Names as Road Safety Questions Mount Five families are waiting for official word. Police have…
-
Bus Overturns Into Gorge Near Chakri Interchange on Pakistan’s M2 Motorway, Killing 6
A devastating bus accident occurred on July 13, 2025, near the village of Chakri, Pakistan, resulting in the loss of six lives…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
How the OncoMate MSI Dx Test Guides Pembrolizumab Therapy
-
NIH Study Links Forever Chemicals to Aggressive Breast Cancer Rates
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
IRS Raises Annual Gift Exclusion to $20,000 for 2027, Enabling $320,000 Tax-Free Transfer for Couples
-
Medicare Part D Cap Rise to $2,400 Outweighs 2027 Ozempic Price Cuts
-
Dave Ramsey Assesses Retirement Viability for a 58-Year-Old With a $3 Million Nest Egg
-
Financial and Systemic Barriers Impede Early Bladder Cancer Care for Younger Veterans